Editor's note channel feed – Endpoints News

Editor's note channel feed

Watch Post-Hoc Live: What happens when AI thinks in ways we can’t understand?

3 days ago

Post-Hoc Live: The fallout from RFK Jr.’s firing of ACIP, with ex-CDC Director Mandy Cohen

5 days ago

Post-Hoc Live: Is biotech sentiment really as bad as it seems?

3 weeks ago

Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’

Last month

Endpoints wins SABEW 'Best in Business' award for Health Tech coverage and newsletter

3 months ago

Post-Hoc: Pharma CEOs' alternative reality with Trump

3 months ago

We’re about to find out which RFK Jr. will show up at HHS

4 months ago

The new China dynamic, Trump 2.0, markets and more: See you tomorrow at JPM!

5 months ago

Post-Hoc: Biosecure is dead. Long live Biosecure?

5 months ago

Post-Hoc: Trying to make sense of a killing

6 months ago

Post-Hoc: RFK vs. Vivek, and the future of US drug policy

7 months ago

Pfizer’s make-or-break quarter

7 months ago

Post-Hoc: Novo’s obesity enemies

7 months ago

Post-Hoc: What does an activist want with Pfizer?

8 months ago

Post-Hoc: Big promises built Moderna. They might also be its undoing

9 months ago

The Endpoints 11 event is coming: Meet biotech’s hottest new startups

9 months ago

See you at BIO: China tensions, fixing gene therapy’s business model, and the stop-start market recovery

Last year

Antitrust, AI and Alzheimer’s: Join us in New York next week

Last year

From the editor: Our final edition of Endpoints MarketingRx

Last year

Introducing Post-Hoc: Our latest newsletter with analysis and insights

Last year

From the newsroom: Endpoints wins a SABEW award for general excellence

Last year

#JPM24 reflections: No politics, no Miami and where the money is in biotech right now

Last year

What we’re doing differently at JP Morgan this year

Last year

Did I ever tell you the one about the drunken biotech awards program I hosted at a Chicago bar?

Last year

12 3 Next page Last page